Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Brian Koopman is Principal Financial Officer at Utah Medical Products. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 30, 2026, each linked to the official Form 4.
Principal Financial Officer
Disclosures on record
2
Companies involved
1
As of the latest filing on , Brian Koopman reported holding 782 shares of Utah Medical Products (UTMD), worth about $56K at the last close of $72 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Utah Medical Products UTMD | 782 | 782 direct | $72 | $56K | May 28, 2026 |
Is this Brian Koopman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Utah Medical ProductsUTMD
2 disclosures · Nov 2025 – May 2026
May 28, 202650disclosed May 30
DetailsOfficial recordOct 31, 2025500disclosed Nov 26
DetailsOfficial recordBrian Koopman has no open-market purchase on record since 2019. Sales in 1 of the 8 years since 2019.
Brian Koopman reported 0 open-market purchases and 1 sale since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2019 | — | $32K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 28, 2026, Brian Koopman reported holding 782 shares of Utah Medical Products (UTMD). At the last close of $72 on Nov 13, 2026, that is about $56K. This is the stake disclosed in filings, not a net worth.
Brian Koopman has no open-market purchase on record since 2019. Sales in 1 of the 8 years since 2019.
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2019.
Utah Medical Products (UTMD), from 2019 to 2019: 0 purchases and 1 sale.
Brian Koopman reported 0 open-market purchases and 1 sale here, 2019.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.